Esprit Pharma
Latest round
- Series B
Last raised
- Aug 2006
Total raised
- $96M
Investors
- 6
About Esprit Pharma
Esprit Pharma, Inc.Founded in 2004 and headquartered in East Brunswick, US, Esprit Pharma, Inc. specializes in producing pharmaceutical products. The company was acquired by Allergan Inc. in September 2007 for USD 370 mn, marking a significant shift in its operational strategy.Esprit Pharma specializes in delivering innovative pharmaceutical products aimed at addressing unmet medical needs. The company's core offerings include a range of prescription medications designed to treat various conditions, particularly in the fields of urology and women's health. These products are developed to enhance patient outcomes through improved efficacy and safety profiles, targeting both healthcare providers and patients directly. Esprit Pharma’s offerings are tailored for specific end-use cases such as chronic urological conditions and gynecological disorders, facilitating better management of these health issues.Esprit Pharma generates revenue through a structured model that includes direct sales to healthcare providers and partnerships with pharmaceutical distributors. The company engages in B2B transactions, allowing it to streamline its product distribution channels effectively. Revenue is primarily derived from the sales of its flagship products, which are marketed under proprietary brand names that emphasize their distinct therapeutic benefits. Pricing plans for these products are established based on various factors including market demand and therapeutic value, ensuring competitive positioning within the pharmaceutical industry.Following its acquisition by Allergan Inc. in September 2007, Esprit Pharma plans to leverage its new resources to enhance treatment options for overactive bladder (OAB) symptoms. Esprit Pharma is exploring opportunities for expanding its market presence in both North America and Europe, targeting new healthcare partnerships and distribution agreements to reach a broader audience.
Who invested in Esprit Pharma
6 investors across 2 rounds
See all investors in Esprit Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Esprit Pharma
Who invested in Esprit Pharma?
Esprit Pharma has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Esprit Pharma raised?
Esprit Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Esprit Pharma last raise money?
Esprit Pharma's most recent round on record is a Series B, in Aug 2006.
What does Esprit Pharma do?
Esprit Pharma is a pharmaceuticals company.
Where is Esprit Pharma headquartered?
Esprit Pharma is headquartered in East Brunswick, US.
Which VCs invest in companies like Esprit Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Esprit Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Esprit Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.